<p>Premature ovarian insufficiency (POI) is one of the most common diseases contributing to declining fertility globally. Autoimmune dysregulation has been implicated in POI, but the role of B cell and its subsets in immune dysregulation in POI remains unclear. In the current study, we investigated whether disturbances in the distribution and functional characteristics of peripheral B cell subsets are associated with POI and its severity. Our results revealed that POI patients exhibited a higher percentage of total CD19<sup>+</sup> B cells, but the proportion of memory B cells (MBCs) and plasmablasts was significantly reduced compared to controls. A notable decrease in interleukin-10 (IL-10) production by B cells was observed, primarily due to a reduction in CD19<sup>+</sup>CD24<sup>hi</sup>CD27<sup>+</sup> and CD19<sup>+</sup>CD24<sup>hi</sup>CD38<sup>hi</sup> regulatory B cells (B<sub>regs</sub>). These alterations correlated with elevated follicle-stimulating hormone (FSH) and decreased anti-Müllerian hormone (AMH) and antral follicle count (AFC) levels. However, no significant differences were observed in the suppressive capacity of B<sub>regs</sub> on interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α) production by autologous CD4<sup>+</sup> T cells in POI patients compared with control women. These findings suggest that B-cell dysregulation may contribute to the immune pathogenesis of POI, providing potential targets for therapeutic intervention.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Peripheral B cell alteration in patients with premature ovarian insufficiency

  • Yueshuang Lu,
  • Hanbing Zhu,
  • Changjing Wang,
  • Pinxin Si,
  • Shutong Meng,
  • Yujie Dang,
  • Wenzhe Zhang,
  • Jiangtao Zhang,
  • Kai Rong,
  • Nianyu Li

摘要

Premature ovarian insufficiency (POI) is one of the most common diseases contributing to declining fertility globally. Autoimmune dysregulation has been implicated in POI, but the role of B cell and its subsets in immune dysregulation in POI remains unclear. In the current study, we investigated whether disturbances in the distribution and functional characteristics of peripheral B cell subsets are associated with POI and its severity. Our results revealed that POI patients exhibited a higher percentage of total CD19+ B cells, but the proportion of memory B cells (MBCs) and plasmablasts was significantly reduced compared to controls. A notable decrease in interleukin-10 (IL-10) production by B cells was observed, primarily due to a reduction in CD19+CD24hiCD27+ and CD19+CD24hiCD38hi regulatory B cells (Bregs). These alterations correlated with elevated follicle-stimulating hormone (FSH) and decreased anti-Müllerian hormone (AMH) and antral follicle count (AFC) levels. However, no significant differences were observed in the suppressive capacity of Bregs on interferon-gamma (IFN-γ) or tumor necrosis factor-alpha (TNF-α) production by autologous CD4+ T cells in POI patients compared with control women. These findings suggest that B-cell dysregulation may contribute to the immune pathogenesis of POI, providing potential targets for therapeutic intervention.